This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gautier, F. Articles by Harb, J. Search for Related Content PubMed PubMed Citation Articles by Gautier, F. Articles by Harb, J.

Identification of an Apoptotic Cleavage Product of BARD1 as an Autoantigen: A Potential Factor in the Antitumoral Response Mediated by Apoptotic Bodies¹

Institut de Biologie, INSERM U419, 44035 Nantes Cédex, France [F. G., M. G., K. M., J. H.] and Department of Geriatrics, University of Geneva, CH-1226 Chêne-Bourg, Switzerland [I. I-F.]

We have shown previously that rats can be cured from induced peritoneal colon carcinomatosis by injections of apoptotic bodies derived from tumor cells and interleukin 2. This curative treatment generated a tumor-specific cytotoxic T-cell response associated with a humoral response. Autoantibodies from sera of cured rats strongly recognized a M_r 67,000 protein from apoptotic bodies and weakly reacted with a protein of M_r 97,000 in PROb parental cells. We now show that these autoantibodies are directed against BARD1, originally identified as a protein interacting with the product of the breast cancer gene 1, BRCA1. We demonstrate that the M_r 67,000 antigen is a cleaved form of BARD1 present in apoptotic bodies derived from rat and human colon and mammary carcinoma cell lines. Moreover, we show that the cleavage site of BARD1 is located NH2 terminally but downstream of the RING domain essential for BARD1 and BRCA1 protein interaction. In vitro studies using [³⁵S]methionine-labeled human BARD1 and apoptotic cellular extracts derived from SW48 carcinoma cells indicate that BARD1 proteolysis occurs at an early stage of apoptosis and in a cell cycle-dependent manner. This hydrolysis is inhibited by EGTA, and the calpain inhibitor I, N-acetyl-leu-leu-norleucinal, but not by several caspases inhibitors, suggesting that BARD1 is hydrolyzed by the calcium-dependent cysteine proteases, calpains. Thus, the highly immunogenic form of cleaved BARD1 could contribute to the antitumoral response mediated by apoptotic bodies.

This article has been cited by other articles:

				L. Li, S. Ryser, E. Dizin, D. Pils, M. Krainer, C. E. Jefford, F. Bertoni, R. Zeillinger, and I. Irminger-Finger Oncogenic BARD1 Isoforms Expressed in Gynecological Cancers Cancer Res., December 15, 2007; 67(24): 11876 - 11885. [Abstract] [Full Text] [PDF]

				V. Tembe and B. R. Henderson BARD1 Translocation to Mitochondria Correlates with Bax Oligomerization, Loss of Mitochondrial Membrane Potential, and Apoptosis J. Biol. Chem., July 13, 2007; 282(28): 20513 - 20522. [Abstract] [Full Text] [PDF]

				A. Feki, C.-E. Jefford, P. Durand, J. Harb, H. Lucas, K.-H. Krause, and I. Irminger-Finger BARD1 Expression During Spermatogenesis Is Associated with Apoptosis and Hormonally Regulated Biol Reprod, November 1, 2004; 71(5): 1614 - 1624. [Abstract] [Full Text] [PDF]

				S. Lafarge and M.-H. Montane Characterization of Arabidopsis thaliana ortholog of the human breast cancer susceptibility gene 1: AtBRCA1, strongly induced by gamma rays Nucleic Acids Res., February 15, 2003; 31(4): 1148 - 1155. [Abstract] [Full Text] [PDF]